Intensification of aquaculture has led to frequent occurrence of disease outbreaks. To deal with this issue antibiotics
are a widely-preferred control strategy, but one that poses risks to the environment and humans, if used
indiscriminately. In pursuit of an alternative, probiotics have emerged recently among viable alternatives for
health management in aquaculture. The prophylactic use of probiotics in farmed shellfish species, i.e., shrimp,
prawn, crab, crayfish, oyster and abalone, has been demonstrated to enhance production, promote the host
internal microbiota, resulting in reduced incidence of bacterial, parasitic and even viral (e.g., White Spot Syndrome
Virus/WSSV, Yellowhead disease/YHD) diseases. Probiotics can be administered either as feed supplements
or directly into rearing water, the former being generally more effective. Although precise modes of action
are unknown, probiotics can deliver some measure of sustainability to shellfish aquaculture in multiple ways,
including contributions to pathogen exclusion, better growth, survival and feed utilization, and immune modulation.
Antiviral mechanisms of probiotics are not well documented, but certain protobionts such as Bacillus and
Lactobacillus have been effective in developing disease resistance and in reducing the prevalence of WSSV and
YHD in a number of studies. This review discusses recent advances on the role of probiotics in shellfish aquaculture,
emphasizing their prophylactic activity against viral diseases.
2. Aquaculture Reports 25 (2022) 101220
2
producers and consumers. To fight those stressors and their negative
impacts, probiotics have become recognized as important substitutes,
acting as immunity modulators and increasing resistance against various
microbial pathogens (Dawood et al., 2018; Madani et al., 2018; Van
Doan et al., 2018).
The term probiotic is coined from Greek pro and bios (meaning “for
life”), which can be understood further from the revised definition of
Merrifield et al. (2010): “a probiotic organism can be regarded as a live,
dead or component of a microbial cell, which can be administered via
feed or into rearing water, benefiting the host by improving growth
performance, feed utilization, immune health status, infectious disease
resistance, and stress responses which is achieved at least in part via
improving the microbial balance in hosts or ambient environment”.
Scientists working with probiotics have noted positive effects on growth
(Farsani et al., 2020; Nargesi et al., 2020), activities of digestive en
zymes and feed utilization (Makled et al., 2020; Yanbo and Zirong,
2006), immunity elevation by way of immune-gene transcription (Beck
et al., 2016; Park et al., 2020), improvement of beneficial gut-microbes
and positive modification of intestinal structure (Akter et al., 2019;
Duan et al., 2018), and protective actions against diseases (Ramesh
et al., 2017; Rengpipat et al., 2000; Van Doan et al., 2018). These pos
itive health influences have the additional benefit of being an
eco-friendly approach to aquatic environmental management (Cha
et al., 2013; Das et al., 2006).
The effective use of probiotics can be influenced by some conditions,
such as the administration methods, appropriateness of the timing of
application, dosages and other physiological factors of the culture spe
cies. It is a good general principal that probiotics are most effective when
applied preventatively into culture systems before any disease outbreaks
occur. Mostly they are designed to be applied as feed additives as
opposed to addition into the culture environment, since administration
of probiotics orally is considered to be a more practical method (Azad
et al., 2005; Gomes et al., 2009; van Hai and Fotedar, 2010).
Probiotics have been found to be effective through several modes of
action. Major activities of probiotics include i) competitive exclusion of
pathogens, ii) stimulation of increased immune responsiveness, iii)
promotion of the production of antimicrobial substances and iv)
enhancement of growth and survival rates. In addition, the inhibitory
effects of probiotics are proven against emerging viral diseases such as
white spot syndrome virus (WSSV), yellow head disease virus (YHD) and
Taura Syndrome virus (TSV) (Lai et al., 2020a; Thammasorn et al., 2017;
Walker and Mohan, 2009).
Among established mechanisms of action, immunomodulation ap
pears to be actively involved in building resistance against viruses.
Probiotics stimulate phagocytic activity, acid phosphatase, lysozymes
and cytokines, all of which enhance the immunocompetence of
shellfishes, increasing their resistance to viral diseases (Chai et al., 2016;
Mamun et al., 2019). In addition, probiotics act as a potential adjuvant
as they stimulate cellular and humoral components of shellfish immune
systems (Sakai, 1999). Moreover, probiotics were found effective to
enhance growth and feed utilization parameters (specific growth rate,
final body weight, weight and length gain, feed efficiency and feed
conversion ratios etc.), water quality parameters (temperature, dis
solved oxygen, pH, nitrate, phosphate, silicate etc.), immune-related
gene expressions and much more (Das et al., 2006; Duan et al., 2019;
Silva-Aciares et al., 2013; Talib et al., 2017).
Aiming to characterize the functionality of probiotics in shellfishes,
an extensive search of the Scopus database revealed more than 200
publications focused on the efficiency of probiotics in shellfish, such as
prawn, shrimps and lobster species, and citations up to the year 2021
have reached about 6000 (Fig. 1). However, considering those publi
cations, this study also focuses on different capacities of probiotics to
wards shellfishes. Besides the enhancement of growth, feed utilization,
water quality and immune-related parameters, probiotics are known to
effectively reduce the viral load and hamper the spread of viral diseases
in shellfishes. Future research on shellfish probiotics should focus on
finding an organized approach to relevant functions of probiotics on
shellfishes such as shrimps, prawns, crabs, crayfishes, lobsters, oysters
and abalones.
2. Mode of action of probiotics
Over the last two decades, a significant number of investigations
have focused on the effects of probiotics as they pertain to disease
resistance, growth performance, microbial balance, intestinal health,
feed utilization, and water quality in farmed shellfish. These studies
have collectively revealed multiple modes and sites of action for pro
biotics applied in aquaculture, leading to the proposal of several
mechanisms of action in the literature (Dawood et al., 2018; Dawood
and Koshio, 2016; Hai, 2015; Hoseinifar et al., 2018; Newaj-Fyzul et al.,
2014; A. Wang et al., 2019), including the formation of inhibiting
compounds, competition with potential pathogens, bolstered immune
response, and improved growth and survival. Probiotic actions have
been reported in larval zebrafishes prior to the initiation of feeding,
indicating improved yolk absorption and nutrient utilization (Padeniya
et al., 2022). These modes of action contribute insights into the diverse
range of positive benefits on aquatic species (Fig. 2), which can differ in
some cases according to developmental status. For a deeper compre
hension of probiotic effectiveness, forthcoming experimentation on the
interaction between probiotic and host needs to incorporate both tran
scriptomic and proteomic analysis. For a better understanding, we
recommend articles on such analysis, such as, Brunt et al. (2008)
Fig. 1. The volume of publications in the Scopus database covering the effects of probiotics on shellfish and their citation numbers (Years: 1998–2021).
T.A. Sumon et al.
3. Aquaculture Reports 25 (2022) 101220
3
(proteomic analysis of Rainbow trout serum after probiotic adminis
tration) and Tacchi et al. (2011) (transcriptomic responses of Atlantic
salmon to functional feeds).
2.1. Competitive exclusion of pathogens
Competitive exclusion has been posed as among possible mecha
nisms of probiotic effect against pathogens (Merrifield et al., 2010;
Newaj-Fyzul et al., 2014; A. Wang et al., 2019). Probiotics enter into the
gastrointestinal (GI) tracts of aquatic organisms in the same way as they
do in terrestrial animals, and can disrupt the function of pathogens
through the production of antagonistic compounds and by competing for
substrates, and resources such as nutrients, physical space, and even
oxygen (Fuller, 1989; Hai, 2015) (Fig. 2). Competition for binding re
ceptors which might antagonize pathogens and limit their colonization
could be the main explanation for this action (Chabrillon et al., 2006;
Luis-Villaseñor et al., 2011). The inhibitory role of probiotics on infec
tious microbes has been investigated in a number of studies. For
instance, LAB was revealed to be inhibitory to Vibrio harveyi and
V. parahaemolyticus in Litopenaeus vannamei and Penaeus indicus
respectively (Ajitha et al., 2004; Vieira et al., 2007). Similarly, Entero
coccus faecium (in Penaeus monodon), Lactococcus lactis subsp. lactis (in
L. vannamei), several Lactobacillus species in shrimps were reported to be
inhibitory towards many Vibrio spp. such as V. harveyi V. alginolyticus
and V. parahaemolyticus (Adel et al., 2017; Karthik et al., 2014; Nguyen
et al., 2018; Sivakumar et al., 2012; Swain et al., 2009). It should be
noted that not all probiotic candidates colonize the GI tract; some
inhabit the skin, gills, and other tissues. In addition, various factors
including passive forces, electrostatic interactions, hydrophobic, steric
forces, and lipoteichoic acids have all been documented to influence
probiotic adherence to binding points (Hoseinifar et al., 2018). Pro
biotics appear to have very good potential for utilization as a replace
ment to antibiotics for disease preventative purposes.
2.2. Immune modulation
One critically important mode of action of probiotics is immuno
modulation, which involves enhancing the host’s immunological
response. In recent years, a growing degree of attention has been
attracted to understanding the underlying mechanism of action of pro
biotics on the immune system of shellfish, in response to numerous re
ports that probiotics stimulate immune function. In tiger shrimp
(Penaeus monodon), dietary Bacillus sp. S11 had a beneficial effect on
cellular and humoral immunity, leading to enhanced protection against
disease (Rengpipat et al., 2000). Moreover, probiotic application of
Clostridium butyricum CBG01 has been demonstrated to augment innate
immunity of whiteleg shrimp (L. vannamei), in which significantly
increased activities of alkaline phosphatase, acid phosphatase, lyso
zyme, and total nitric oxide synthase were observed with elevated res
piratory burst activity (Li et al., 2019a). Moreover, increases in other
innate and cellular immune parameters such as heamolymph bacteri
cidal activity (Chandran et al., 2014; Rengpipat et al., 2000), phagocytic
activity (Liu et al., 2014; Y. C. Wang et al., 2019; Zhao et al., 2019),
superoxide dismutase (SOD) (Miao et al., 2020; Tseng et al., 2009), total
anti-oxidant capacity (Amoah et al., 2020; Duan et al., 2017), total
haemocyte count (Dash et al., 2015; Kumar et al., 2013), catalase (Hindu
et al., 2018; Miao et al., 2020), phenoloxidase (Rahiman et al., 2010)
and prophenoloxidase (proPO) (Kolanchinathan et al., 2017) have been
described among effects of probiotics in multiple shellfish species
(Fig. 2). Furthermore, numerous studies have demonstrated that adding
probiotics to shellfish diets improves the expression of immunological
and stress-related genes. including pen-3a (Chai et al., 2016; Tepaa
morndech et al., 2019), proPO (Li et al., 2019b; Wu et al., 2014), SOD
(Sánchez-Ortiz et al., 2016; Yang et al., 2019), HSP70 (Duan et al., 2018;
Miao et al., 2020), lipopolysaccharide and β-1, 3-glucan binding protein
(LGBP) (Hao et al., 2014; Interaminense et al., 2019).
Fig. 2. Mode of action of probiotic microorganisms in shellfish. A) Competitive exclusion of pathogens like Vibrio sp., Vibrio anguillarum, white spot syndrome virus,
yellow head virus, taura syndrome virus etc. B) Development of the immune system is another important mode of action of probiotics in shellfishes, where they
increase alkaline and acid phosphatase activities and provide protection against bacterial, viral and parasitic diseases. C) Probiotic also produce many antimicrobial
substances, e.g., bacteriocin, nisin, lysozyme enzymes and bactericidal proteins and so on. D) Probiotics like Bacillus, Lactobacillus, Clostridium etc. enhance growth
and survival rates of shellfishes through enhancing feed utilizations, increasing digestive enzyme activities and producing vital nutrients.
T.A. Sumon et al.
4. Aquaculture Reports 25 (2022) 101220
4
2.3. Production of antimicrobial compounds
Probiotics are employed as an alternative to antimicrobial agents
such as antibiotics and chemicals in shellfish farming (Decamp et al.,
2008; Van Hai et al., 2009). Although the specific mechanism by which
probiotics exhibit antibacterial properties is still unknown, numerous
investigations have suggested that a variety of probiotic species generate
bactericidal molecules such as bacteriocin, siderophore and lysozyme
enzymes (Hai, 2015; Hoseinifar et al., 2018). Immune systems of
shellfishes have been activated by these molecules, increasing their
resistance to infections by viruses, bacteria, fungi, and parasites (Fig. 2).
Digestion and fermentation of non-digestible fibers and polysaccharides
by probiotics led to formation of a group of fermented short- and
medium-chain fatty acids which reduce the pH in the intestine, thereby
inhibiting pathogenic bacteria (Dawood, 2021; Ma et al., 2009). In
addition, common probiotic bacteria like Lactobacillus spp. have been
found to inhibit pathogens via the generation of short chain fatty acids,
diacetyl, hydro peroxide, and bactericidal proteins (Hai, 2015; Rengpi
pat et al., 1998; Verschuere et al., 2000).
2.4. Promotion of growth and survival
The activity of digestive enzymes is closely associated with healthy
feed intake, digestion ability, growth rates, and the general health of the
host species (A. Wang et al., 2019). By augmenting the functionalities of
digestive enzymes, probiotics improve feed utilization and growth in
shellfish (Newaj-Fyzul et al., 2014). Significantly higher growth rate,
feed utilization and protease enzyme activity were observed in whiteleg
shrimp following the administration of Bacillus subtilis E20 (Liu et al.,
2009). Probiotic Clostridium butyricum has been shown to enhance the
growth performance and feed conversion ratio (FCR) of tiger shrimp
(Duan et al., 2018). Similarly, a combination of three probiotic strains
fed to ornate spiny lobster (Panulirus ornatus) promoted higher weight
gain with increased specific growth rate and FCR (V. D. Nguyen et al.,
2014). Synthesis of extracellular enzymes such as proteases, lipases and
amylases have been reported in response to probiotics, with evidence
that increases in digestive enzyme production result in improved
digestive function (Adel et al., 2017; Amoah et al., 2020; Seenivasan
et al., 2016; Sumon et al., 2018). Additionally, probiotics might enhance
the uptake and utilization of nutrients and micronutrients, since the
application of probiotics resulted in the production of vital materials
such as vitamin B12, fatty acids, and biotin (Hai, 2015; Verschuere et al.,
2000; Vine et al., 2006). One net effect is that feeding probiotics to
shellfish has been confirmed to boost survival rates. (Zokaeifar et al.,
2012) reported higher survival rate of whiteleg shrimp (Litopenaeus
vannamei) upon dietary supplementation of two strains of B. subtilis (L10
and G1). Agarivorans albus strain F1-UM and Vibrio sp.-fed abalone
(Haliotis rufescens) (Silva-Aciares et al., 2013) and Bacillus-fed mud crab
(Scylla paramamosain) (Talib et al., 2017) also had notably higher sur
vival rates during challenges with Vibrio parahaemolyticus and Vibrio sp.
respectively.
3. Antiviral activity/ability of probiotics
The diseases of aquatic animals that have been reported for centuries
are mostly either non-infectious or caused by parasites, bacteria, or
other pathogens. However, in last few decades the culture of aquatic
animals has undergone a series of intensifications, including some
extremely intensive methods. Accordingly, the global improvement of
aquaculture production systems became associated with various stresses
to the aquatic ecosystems and the emergence of a number of new dis
eases in fish and shrimp. Shrimps are the largest seafood commodity,
contributing around 17% in globally-traded fishery products, and they
are often cultured intensively. Diseases have had a disproportionately
heavy impact on the shrimp industry, and they are recognized as criti
cally important limiting factors (Lakshmi et al., 2013; Walker and
Mohan, 2009; Walker and Winton, 2010). The growth of shrimp farming
is constrained by diseases but treating and preventing them with ranges
of chemicals - particularly antimicrobial agents – has had a catastrophic
impact on the industry. The infusion of tons of antibiotics into aquatic
environments has resulted in the accumulation of harmful residues in
commercial shellfish produced for human consumption. In addition,
these antibiotics also devastate the normal microbial communities,
including numerous benevolent bacteria, thereby promoting the prolif
eration of resistant pathogens and compromising shrimp and fish pro
duction (Grave et al., 1999; Lakshmi et al., 2013; Le and Munekage,
2004). The only microbes that can survive such chemical attacks are
antibiotic-resistant strains, and consequently this strategy for control
has led to the emergence of “superbugs”, or antibiotic-resistant strains of
pathogens. As a result, alternatives to antibiotics become a crucial,
extremely high-priority industry need.
Besides bacterial and parasitic pathogens, a series of novel viral
pathogens of shrimp have continued to emerge since the 1970 s, such as
monodon baculovirus (1977), hepatopancreatic parvovirus (1983),
Yellow Head Virus - YHV (1990), White Spot Syndrome virus - WSSV
(1992), Taura Syndrome virus - TSV (1992) and so on (Walker and
Mohan, 2009). Viruses evolve extremely fast – a painful lesson that we
have learned in the course of the Covid pandemic. The viral life cycle is
as short as a single day, enabling mutant strains to become established
extremely quickly. Among aquatic pathogenic viruses, WSSV has caused
huge economic losses worldwide, and no commercial vaccine to
improve adaptive immunity against WSSV is available to date (Pham
et al., 2017; Sánchez-Martínez et al., 2007). Recently, a number of sci
entists have identified the potential of probiotics to improve resistance
of shellfishes against viral diseases like White Spot Syndrome (WSS) and
YHV disease (Table 1).
In most cases, Bacillus and LABs (including Lactobacillus) have been
used experimentally, and many of these LAB species have been found
effective to reduce mortality due to WSSV and YHV. Moreover, WSSV
prevalence has been significantly reduced after administration of some
probiotic microorganisms. Additionally, the immune system of shrimps
responded positively to probiotics in nearly all experiments, leading to
improved shrimp health (Chai et al., 2016; Partida-Arangure et al.,
2013; Thammasorn et al., 2017). For instance, Chai and coworkers (Chai
et al., 2016) found the PC465 strain of Bacillus decreased the tran
scription of crustin in hemocytes of L. vannamei, which is responsible for
inhibiting replication of WSSV and the reduction of mortality in
WSSV-challenged shrimps, thereby providing some protection against
WSS (Chai et al., 2016). Likewise, Lai and his colleagues found Bacillus
amyloliquefaciens to stimulate innate immunity, resulting in reduced
copy numbers of WSSV and significantly reduced mortality of
WSSV-challenged crayfish (Lai et al., 2020b). In providing resistance to
WSSV and prophylaxis treatment, probiotics have also been found
effective. For example, the VP28 candidate antigen vaccine using
B. subtilis spores decreased the death rate to 33% from 66% of otherwise
untreated whiteleg shrimps. In addition, a 75% protection rate was
found in the case of tiger shrimps ( A. T. V Nguyen et al., 2014; Pham
et al., 2017).
To recapitulate, as there are some probiotics that potentially
inhibited or reduced or provided resistance to WSSV, this should be
subjected to intense scientific pursuit. The inhibitory capacity of pro
biotics against WSSV could serve as a model for the management of
other emerging viral diseases. To achieve this, a systemic and accurate
method of studying antiviral activity of probiotics should be established
first. In this context, Lakshmi et al. (2013) suggested some modifications
to the cell culture model proposed by Botić et al. (2007), in which
probiotic bacteria exclude pathogens through competition for attach
ment sites coupled with the stimulation of host cell immune defenses in
humans (Isolauri, 2003). The proposed cell culture model could include
several antiviral assays, such as the incubation of cell lines with viable
probiotic bacteria, or the viruses and bacteria could be administered
simultaneously to the cell lines, or the bacteria and virus could be
T.A. Sumon et al.
5. Aquaculture Reports 25 (2022) 101220
5
co-incubated, or the supernatants containing products of viable pro
biotic bacteria could be added in the cell lines as components of the
incubation media (Lakshmi et al., 2013). However, the application of
probiotics in shellfish culture is a safe and novel tactic. Further experi
mental attention should focus on the mechanisms involved in probiotic
resistance to viral infections.
4. Effects of probiotics on shellfish
4.1. Whiteleg shrimp
Whiteleg shrimp, L. vannamei (also known as Pacific white shrimp) is
the most cultured crustacean species, accounting for nearly 53% of total
global crustacean production. It is a genetically improved and
domesticated species. Production of L. vannamei has substantially surged
to 4.156 million tonnes (MT) in 2018, up from 1.13 MT in 2000 (FAO,
2020); alternative favorite species such as Penaeus monodon have not
come close to keeping pace with the industry-dominating growth of
P. vannamei. Disease occurrence also coupled with increased and
intensified production of this species, accounts for significant financial
losses for the aquaculture industry. The effect of probiotics on whiteleg
shrimp has piqued researchers’ interest in recent years, resulting in the
highest number of studies among shellfish. The Scopus database yielded
a total of 97 articles on the application of probiotics in L. vannamei as of
July 16, 2021 (Fig. 1).
Whiteleg shrimp have been treated with a diversity of microorgan
isms as probiotics, producing a variety of beneficial effects, including
enhancement of growth performance, immune response and protection
against various pathogens, including V. harveyi, V. alginolyticus,
V. campbellii, V. parahaemolyticus, and WSSV (Table 2). Among the
studied probiotic candidates, Bacillus spp., Lactobacillus spp., and Clos
tridium spp. are the most extensively utilized species (Butt et al., 2021).
In addition, the yeast probiotic Saccharomyces cerevisiae has been shown
to be helpful in a number of investigations (Ayiku et al., 2020; Y. C.
Wang et al., 2019). These probiotics are derived from a variety of
sources, most of which have been cultured from the guts of healthy
specimens of the host species (Kewcharoen and Srisapoome, 2019;
Kongnum and Hongpattarakere, 2012; Liu et al., 2014). A summary of
the effects of probiotics in whiteleg shrimp aquaculture is presented in
Table 2.
The majority of probiotic investigations on this shrimp species have
focused on single-species probiotic treatment (Adel et al., 2017; Duan
et al., 2017; Shen et al., 2010; Tseng et al., 2009). Kewcharoen and
Srisapoome (2019) fed white shrimp a diet supplemented with
host-derived B. subtilis AQAHBS001 for five weeks at different concen
trations: 105
, 107
and 109
CFU g–1
. When compared to the control
treatment, probiotic-treated shrimp demonstrated significantly
improved growth, feed conversion ratios (FCR), and immunological
responses as revealed by increased phagocytic activity and clearance
efficiency. Furthermore, probiotic found to augment disease resistance
of shrimp against Vibrio parahaemolyticus AHPND by upregulating the
expression of immune-related genes and increasing microvilli and in
testinal wall thickness. In another six–weeks experiment, addition of
Lab. plantarum MRO3.12 (2 – 4 ×108
CFU g–1
) isolated from digestive
tract of wild shrimp to the diet improved growth, feed efficiency and
survival rate of white shrimp (Kongnum and Hongpattarakere, 2012).
Furthermore, when challenged with V. harveyi, probiotic-fed shrimp had
a 30% higher survival rate than the control group.
Multi-strain probiotics have garnered interest recently owing to their
cumulative favorable impact with higher potency against a broader
range of pathogenic microorganisms. However, a mixture of probiotics
has been shown to yield enhanced benefits to the hosts compared to
probiotics administered singularly, although shrimps do not consistently
benefit from exposure to such combinations of species. For instance, Cai
et al. (2019) evaluated the effect of B. licheniformis, B. flexus and their
mixture in L. vannamei postlarvae after feeding probiotic included diet
for 21 days. These authors reported that these two strains not only
increased the growth, survival, digestive enzyme functions, innate im
munity, stress tolerance and disease resistance against V. harveyi, but
also elevated the quality of rearing water. Likewise, administration of
single or combined Shewanella haliotis D4, B. cereus D7 and Aeromonas
bivalvium D15 at 107
CFU g− 1
added to the feed of the whiteleg shrimps
for 28 days was demonstrated to modulate non-specific immune pa
rameters (Hao et al., 2014). Probiotics-fed shrimp displayed increased
activities of respiratory burst, lysozyme, superoxide dismutase and acid
phosphatase, as well as upregulated expression of genes such as lipo
polysaccharide and β-1,3-glucan binding protein (LHBP), prophenolox
idase (proPO) and penaeidin 3 (Pen 3).
Some investigations have explored the use of probiotics as water
supplements, as opposed to frequent analyses of the dietary application
Table 1
Effects of probiotics against viral diseases of shellfish.
Probiotics Shellfish
species
Action against
viral diseases
References
Bacillus Lactic acid
Bacteria (LAB)
Litopenaeus
vannamei
Improved host
immunity
Reduced
prevalence of
White Spot
Syndrome Virus
(WSSV)
(Partida-Arangure
et al., 2013)
Bacillus PC465 Litopenaeus
vannamei
Immune
enhancement of
shrimp
Reduced copy
number of WSSV
Protection
against WSSV
(Chai et al., 2016)
Bacillus OJ Litopenaeus
vannamei
Increased
immune response
and resistance to
WSSV with
increasing doses
(Li et al., 2009)
Probiotic mixture of
four LAB with
extract and
powdered forms
of plant
Litopenaeus
vannamei
High survival
rate and low
prevalence of
WSSV
(Peraza-Gómez
et al., 2011, 2009)
Lactobacillus
plantarum
Penaeus
vannamei
Promoted shrimp
health against
viruses
Reduced copy
number of
Yellow head
virus (YHV)
(Thammasorn
et al., 2017)
Bacillus
amyloliquefaciens
Procambarus
clarkia
(crayfish)
Regulate innate
immunity
Reduced copy
number of WSSV
Significantly
reduced
mortality of
crayfish
challenged with
WSSV
(Lai et al., 2020)
Bacillus subtilis with
VP28 gene
Litopenaeus
vannamei
Increased
survival of
shrimp
challenged with
WSSV
(Fu et al., 2011)
Bacillus subtilis with
VP28 gene
Fenneropenaeus
chinensis
Significant
resistance to
WSSV
(Fu et al., 2010)
Bacillus subtilis with
VP28 gene
Penaeus
monodon
Found effective
against White
Spot Syndrome
(WSS)
(Pham et al., 2017)
Bacillus subtilis with
VP28 gene
Litopenaeus
vannamei
Found effective
against WSS
(A.T.V. Nguyen
et al., 2014)
T.A. Sumon et al.
6. Aquaculture Reports 25 (2022) 101220
6
Table 2
Influence of probiotics on growth, feed utilization, immunological and haemato-biochemical parameters, and disease resistance in whiteleg shrimp (Litopenaeus
vannamei). Symbol: (→) no change; (↑) increase; (↓) decrease.
Probiotics Mode of administration and dosage Duration Effects on Litopenaeus vannamei References
Bacillus subtilis Dietary supplementation at 104
,
5 × 104
& 105
CFU g–1
40 days GP WG↑; SR→; HBP ALP & ACP→; IP TAC, SOD, GPx, RB,
PO & SL↑, and MDA & CAT→
(Shen et al., 2010)
B. subtilis S12 Dietary supplementation at 5 × (109
,
1010
& 1011
) CFU kg–1
8 weeks GP WG & SGR→; FUP FCR→; IP PcA, SL, SOD, SBA & PO↑,
and THC→; SR↑; IDR Vibrio harveyi↑
(Liu et al., 2014)
B. subtilis E20 Dietary supplementation at 107
, 108
& 10 CFU kg–1
98 days GP WG↑; FUP FCR↓; SR→; DEA PrA↑ (Liu et al., 2009)
B. subtilis E20 Dietary supplementation at 106
, 107
& 108
CFU kg–1
56 days GP FBW, WG & SGR↑; IP THC, RB, PO & SOD↑; IDR Vibrio
alginolyticus↑
(Adilah et al., 2022)
B. subtilis AQAHBS001 Dietary supplementation at 105
, 107
& 109
CFU g–1
5 weeks GP FBW, WG & SGR↑; FUP FCR↓; SR→; IRGE SOD, SL,
proPO & ALF↑; Gut Morphology ↑; IDR V.
parahaemolyticus ↑
(Kewcharoen and
Srisapoome, 2019)
B. subtilis, B. megaterium, B. cereus & B. infantis Dietary supplementation at 108
CFU
g–1
6 weeks GP WG, FBW & SGR→; FUP FCR↓; SR↑; IP SOD, CAT &
PO↓; DEA PrA, AmA, Lipase & Cellulase↑
(Tamilarasu et al.,
2021)
B. aryabhattai TBRC8450 Dietary supplementation at 108
CFU
g–1
6 weeks IR PO & TAC↑; IRGE Pen-3a, Lec-3, Trx, HSP60 & fer↑, and
SP, CAT, SOD, GPx→, and LGBP↓; IDR V. harveyi↑; GutM
Vibrio spp.↓, and Bacterial diversity↑
(Tepaamorndech
et al., 2019)
B. subtilis L10 + B. subtilis G1 Dietary supplementation at 105
&
108
CFU g–1
8 weeks GP FBW, WG & SGR↑; FUP FCR→; SR↑; DEA PrA &
AmA↑; IRGE proPO, PE, LGBP & SP↑; IDR V. harveyi↑
(Zokaeifar et al.,
2012)
B. subtilis L10 + B. subtilis G1 Water supplementation at 105
& 108
CFU mL–1
8 weeks GP FBW, WG & SGR↑; FUP FCR↓; SR↑; DEA PrA & AmA↑;
IRGE proPO, PE, LGBP & SP↑; WQP Ammonia, Nitrite &
Nitrate ions↓; IDR V. harveyi↑
(Zokaeifar et al.,
2014)
Bacilli (50% B. subtilis & 50% B. licheniformis) Dietary supplementation at 104
&
108
CFU g–1
60 days GP WG & SGR↑; FUP FCR↓; SR↑; HBP Glu & Cortisol↓, and
ALB→; IP SL, THC & Ig↑
(Madani et al., 2018)
Photosynthetic bacteria & Bacillus sp. Dietary supplementation at 2, 10 &
20 g kg–1
28 days GP WG↑; DEA PrA, AmA, Lipase & Cellulase↑ (Wang, 2007)
B. subtilis & Shewanella algae Dietary supplementation at 106
CFU
g–1
60 days GP FBW↑; IRGE proPO, LGBP & HEM↑; IDR
V. parahaemolyticus↑
(Interaminense et al.,
2019)
B. licheniformis MAt32 + B. subtilis
MAt43 + B. subtilis subsp. subtilis GAtB1
Dietary supplementation at (1, 2, 4 &
6) × 106
CFU g–1
32 days GP SGR↑, and FBW→; Prevalence WSSV & IHHNV↓;
SR→; IRGE proPO, LvToll1 & SOD↑, and HSP70↓, and
TGase→
(Sánchez-Ortiz et al.,
2016)
B. licheniformis, B. flexus, B. licheniformis
+ B. flexus
Dietary supplementation at 2 × 109
CFU g–1
21 days GP FBW & SGR↑; HBP ALP↑; IP MPO & SL↑; SR↑; DEA
PrA & Lipase↑, and AmA→; WQP Ammonia & COD↓; ESC
Freshwater↑; IDR V. harveyi↑
(Cai et al., 2019)
Shewanella haliotis D4, B. cereus D7, Aeromonas
bivalvium D15, & their mixture
Dietary supplementation at 107
CFU
g− 1
28 days GP FBW, WG & SGR↑; IP RB, SL, ACP & SOD↑; IRGE proPO,
LGBP & Pen-3a↑; IDR V. harveyi↑
(Hao et al., 2014)
Clostridium butyricum Dietary supplementation at 0.25, 0.5
& 1%
56 days GP WG & SGR↑; FUP FCR↓; IP TAC, SL & iNOS↑, and NO→;
IRGE Toll, Imd, & HSP70↑; DEA AmA, PrA & Lipase↑;
SR→; Gut Morphology Intestine epithelium height↑;
Intestine scFA↑; ESC Ammonia↑
(Duan et al., 2017)
C. butyricum Dietary supplementation at (2.5, 5 &
10) × 109
CFU g–1
56 days GutM Bacillus, Clostridium, Lachmoclostridium, Lachnospiraceae
& Lactobacillus↑, and Desulfovibrio & Desulfobulbus↓; DGE
α-amylase, lipase, trypsin, fatty acid-binding protein & fatty acid
synthase↑; IRGE proPO, LGBP, SL, Crustin & SOD↑;
(Duan et al., 2018)
C. butyricum CBG01 (fermentation supernatant
[FS]; live cells [LC]; cell-free extract [CE];
spray-dried spores [DS]; mixture of live cells
& supernatant [LCS])
Dietary supplementation at 1011
CFU
kg–1
of LC, DS, & CE, 120 mL kg–1
(FS), & 1011
CFU kg–1
LC
+ 120 mL kg–1
FS
42 days GP FBW & SGR↑; FUP FCR↓; SR→; IRGE SOD, SL, proPO,
Toll, Imd & Relish↑; Gut Morphology VH & Intestinal wall
thickness↑; IDR V. parahaemolyticus↑
(Li et al., 2019a)
C. butyricum CBG01 Dietary supplementation at 107
to
1012
CFU kg–1
42 days GP WG & SGR↑; FUP FCR↓; SR→; HBP ALP↑; IP SL, RB,
NO, ACP & SOD↑; IRGE Toll, Imd & Relish↑; Gut
Morphology VH & Intestinal wall thickness↑; IDR
V. parahaemolyticus↑
(Li et al., 2019b)
Lactobacillus plantarum Dietary supplementation at 109
CFU
mL–1
45 days GP FBW, WG & SGR↑; FUP FCR↓; IRGE proPO, SOD & SL
(at stress challenge) ↑; ESC Low salinity↑
(Zheng et al., 2017)
Lab. plantarum Dietary supplementation at 109
CFU
mL–1
15 days GP FBW, WG & SGR↑; FUP FCR↓; DEA AmA, Lipase &
Pepsin↑; Gut Morphology Enterocytes height↑
(Zheng et al., 2018)
Lab. plantarum MRO3.12 Dietary supplementation at
2–4 × 108
CFU g–1
6 weeks GP WG & FBW↑; FUP FCR↓; SR↑; IP THC↑; GutM LAB↑;
IDR V. harveyi↑
(Kongnum and
Hongpattarakere,
2012)
Lab. pentosus AS13 Dietary supplementation at 106
, 107
& 108
CFU g–1
28 days GP WG & SGR↑; FUP FCR↓; SR→; DEA PrA & Cellulase↑,
and Lipase→; IDR V. vulnificus, V. rotiferianus & V. campbellii↑
(Zheng and Wang,
2017)
Lab. pentosus HC-2 Dietary supplementation at 5 × 108
CFU g–1
6 weeks GP WG & FBW→; FUP FER→; SR↑; IRGE Rab, GST,
mucin-like-PM, Dorsal & proPO↓, and Relish→; GutM ↑
(Fang et al., 2020)
Lab. pentosus BD6, Lab. fermentum LW2,
B. subtilis E20, & Saccharomyces cerevisiae
P13
Dietary supplementation at 107
, 108
& 109
CFU kg–1
56 days GP WG↑; FUP FER↑; SR→; IP PO, RB, SL, SOD & PcA↑;
IDR V. alginolyticus↑
(Y.C. Wang et al.,
2019)
Pediococcus pentosaceus Dietary supplementation at 106
, 107
& 108
CFU g–1
8 weeks GP WG, FBW & SGR↑; FUP FCR↓; HBP THC↑; IP SL↑;
DEA PrA & AmA↑, and Cellulase→; SR↑; GutM Lactobacillus
sp. & Bacillus sp.↑, and Vibrio sp.↓; IDR V. anguillarum↑
(Adel et al., 2017)
Paenibacillus polymyxa ATCC 842 Dietary supplementation at 106
, 107
& 108
CFU g–1
8 weeks GP WG, FBW & SGR↑; FUP PER↑, and FCR↓; HBP TSP, Alb,
Glb, TG & ALP↑, and AST & ALT↓; IP SL, ACP, TAC, SOD &
GPx↑, and MDA↓; DEA AmA, Trypsin & Lipase↑; Gut
Morphology VH and width & Muscle thickness↑; GutM
(Amoah et al., 2020)
(continued on next page)
T.A. Sumon et al.
7. Aquaculture Reports 25 (2022) 101220
7
of probiotics in white shrimp (Wu et al., 2016; Xia et al., 2014; Zokaeifar
et al., 2014). Wu et al. (2016) reported that administering probiotic
B. subtilis FY99–01 to the water enhanced water quality by lowering pH,
nitrite, and soluble reactive phosphorus levels, but had no influence on
shrimp growth, survival, or FCR. In contrast, Zokaeifar et al. (2014)
observed that supplementation of B. subtilis strains (L10 + G1) in the
rearing water of L. vannamei at 105
and 108
CFU mL–1
conferred bene
ficial effects to water quality, apparently enhancing growth parameters,
gastrointestinal enzyme activities along with elevated immune response
and effective inhibition of V. harveyi.
4.2. Tiger shrimp
The tiger shrimp, Penaeus monodon a commercially important species
primarily in Asia, contributed 9% of total global crustacean production
in 2016 (FAO, 2020). The recent development of intensive culture sys
tem and environmental deterioration have caused frequent disease
outbreaks, for which effective treatment measures are lacking (Duan
et al., 2019). Up to 41 research articles have been found in the Scopus
database on probiotic application for growth, immunity and disease
resistance modulation of this species. Unlike L. vannamei, P. monodon
has not been domesticated because breeding is a relatively more
time-cosuming and expensive process involving artificial insemination
(Muthu and Laxminarayana, 1984).
Different types of probiotics (single and multiple) application effects
on P. monodon are summarized in Table 3. Most of the supplemented
probiotics in P. monodon were isolated from this species’ intestine and
Bacillus as well as lactic acid bacteria (LAB) were mostly supplemented
(80–120 days) probiotics for shrimp. Single dose of Bacillus S11 and P11
produced increased growth and some degree of resistance to V. harveyi
disease (Rengpipat et al., 2000, 1998; Utiswannakul et al., 2011). Ba
cillus S11 and P11 are different regarding cell size, physical appearance
and optimal growth temperature. Colonization of Bacillus S11 in the
shrimp gut acts as competitor against infectious pathogens, thereby
interfering with infectious disease outbreaks (Meunpol et al., 2003).
Presence of amorphous poly-betahydroxybutyrate (PHB) in Bacillus
JL47 is the main causal factor of immune genes transcription as well as
protection of Vibrio challenge (Laranja et al., 2017). It should be noted
that sometimes shrimp growth performance in re-circulatory aquacul
ture systems (RACs) might be slower than outdoor pond culture, due to
filtration of important nutritive compounds for water quality manage
ment. Aquatic bacteria are abundant in aquaculture environments, and
they can play important roles like continuation of geochemical cycles
and activity in fish immune systems (Fig. 3). Bacillus strains are
commonly used as probiotics in commercial aquaculture because of
their spore formation ability and stability in aquatic environments as
well as in the intestine. Live and freeze-dried B. subtilis, B. polymyxa,
B. megaterium, B. licheniformis and B. thuringiensis improved Bacillus
concentration in hepatopancreas and intestine by lowering the Vibrio
count (Boonthai et al., 2011). Probiotics like B. cereus (0.4%) (Chandran
et al., 2014) and Streptomyces sp. (Das et al., 2006) showed highly
favorable outcomes for the modulation of vitally important water
quality parameters such as the abundance of dissolved ammonia, alka
linity, nitrate, phosphate and the salinity of culture water.
Most of the LAB (Lactobacillus) produce bactericidal proteins with
demonstrable antimicrobial activity against both gram-positive and
gram-negative pathogens. Both Lactobacillus sp. AMET1506 and Lab.
acidophilus 04 improved shrimp growth and decreased E. coli (Karthik
et al., 2014) and Vibrio spp. (Sivakumar et al., 2012) concentration in
GIT, respectively.
Probiotics generally increase digestive enzyme activity by the
secretion of exoenzymes in the intestine, thereby improving digestion
and absorption of ingested food resulting in better growth and FUPs.
B. subtilis + B. licheniformis and B. subtilis & Enterococcus sp. improved
the level of 4 digestive enzymes, such as protease, amylase, lipase and
cellulases (Wang et al., 2020) and only trypsin (Nimrat et al., 2013),
respectively. Supplementation of Pseudomonas sp. PM 11 & V. fluvialis
PM 17 to culture water (Alavandi et al., 2004) and B. coagulans
+ B. firmus by diet (Kolanchinathan et al., 2017) upregulated innate
immune parameters of shrimp. Streptococcus phocae and Enterococcus
faecium exposure resulted in the production of bacteriocin and other
antibacterial substances, producing pores on the cell wall of
V. parahaemolyticus, Listrea monocytogenes and E. coli and efflux of
K+ ions, leading to the mortality of these pathogens. Shrimp fed with
S. phocae PI80 and E. faecium MC13 upregulated growth parameters and
infection of V. harveyi and V. parahaemoliticus, respectively (Swain et al.,
Table 2 (continued)
Probiotics Mode of administration and dosage Duration Effects on Litopenaeus vannamei References
Ruegeria & Pseudoalteromonas↑, and Vibrio, Photobacterium,
Tenacibaculum & Shewanella↓; IDR V. parahaemolyticus↑
Arthrobacter sp. CW9 Water supplementation at 105
, 106
&
107
CFU mL–1
24 days GP FBW↑; SR↑; IP PO & PcA↑ (Xia et al., 2014)
B. subtilis FY99–01 Water supplementation at 5 × 104
CFU mL–1
84 days FUP FCR→; SR →; WQP pH, Nitrite & Soluble reactive
phosphorus↓; Water Microbiota Flavobacteria↑, and
α-Proteobacteria & Vibrionaceae↓
(Wu et al., 2016)
Bacillus PC465 Dietary supplementation at 107
&
109
CFU g–1
30 days GP WG↑; SR↑; DEA AmA & PrA↑; IRGE Pen-3a, Lec-3, Trx,
proPO & Peroxinectin↑; PCI↑; IDR WSSV↑
(Chai et al., 2016)
Saccharomyces cerevisiae Dietary supplementation at 1% & 2% 8 weeks GP WG, FBW & SGR↑; FUP FCR↓; HBP TSP, AST, ACP &
ALP↑, and Glu & ALT↓, and TG & TC→; IP SL, SOD, PO &
CAT↑; Gut Morphology VH and width & Muscle
thickness↑; GutM ↑; IDR V. harveyi↑
(Ayiku et al., 2020)
B. subtilis, B. subtilis+B. pumilus Dietary supplementation at
2.1 × 107
, 4.4 × 107
, 1.6 × 107
, and
3.5 × 107
CFU g–1
10
weeks
GP WG, FBW & SGR↑; FUP FCR↓; IP RB, SOD & GPx↑; (Lee et al., 2021)
ACP: Acid phosphatase; Alb: Albumin, ALP: Alkaline phosphatase; ALT: Alanine aminotransferase; AmA: Amylase activity; AST: Aspartate aminotransferase; CAT:
Catalase; COD: Chemical oxygen demand; DEA: Digestive enzyme activities; ESC: Environmental stress challenge; FBW: Final body weight; FCR: Feed conversion ratio;
FER: Feed efficiency ratio; fer: Ferritin; FUP: Feed utilization parameters; Glb: Globulin; Glu: Glucose; GP: Growth parameters; GPx: Glutathione peroxidase; GutM: Gut
microbiota; HBP: Haemato-biochemical parameters; HEM: Hemocyanin; HSP: Heat shock protein; IDR: Infectious disease resistance; Ig: Immunoglobulin; IHHNV:
Infectious hypodermal and hematopoietic necrosis virus; Imd: Immune deficiency; iNOS: Inducible nitric oxide synthase; IP: Immunological parameters; IRGE: Immune
related gene expression; LAB: Lactic acid bacteria; Lec-3: C-type lectin 3; LGBP: Lipopolysaccharide and β-1,3-glucan binding protein; LvToll: Toll receptor; MDA:
Malondialdehyde; MPO: Myloperoxidase; NO: Nitric oxide; PcA: Phagocytic activity; PCI: Probiotic count in the intestine; PE: Peroxinectin; Pen-3a: Penaeidin 3a; PER:
Protein efficiency ratio; PO: Phenoloxidase; PrA: Protease activity; proPO: Prophenoloxidase; RB: Respiratory burst (NBT assay); SBA: Serum bactericidal activity;
scFA: Short chain fatty acid; SGR: Specific growth rate (%); SL: Serum lysozyme; SOD: Superoxide dismutase; SP: Serine protein; SR: Survival rate; TAC: Total anti-
oxidant capacity; TG: Triglyceride; TGase: Transglutaminase; THC: Total hematocyte count; Trx: Thioredoxin; TSP: Total serum protein; VH: Villous height; WG:
Weight gain (%); WQP: Water quality parameters; WSSV: White spot syndrome virus.
T.A. Sumon et al.
8. Aquaculture Reports 25 (2022) 101220
8
2009). Application of C. butyricum improved shrimp digestive enzymes
activity along with immune genes transcription (Duan et al., 2019).
4.3. Giant river prawn
The giant river prawn, Macrobrachium rosenbergii is a cultured crus
tacean for which there is growing and impressive market demand, with
worldwide production of 2.34 million tons in 2016, contributing 3% of
total global crustacean production (FAO, 2020). Application of pro
biotics in prawn aquaculture is gaining favor as an environmentally
friendly means of enhancing health (Gatesoupe, 1999; Zhao et al.,
2019). Intensive research is underway, focused among other things on
dietary supplementation with different species of Lactobacillus and Ba
cillus genera, however C. butyricum, E. faecalis and S. cerevisiae have also
been administrated. In the Scopus database, 38 articles are available on
probiotics application in M. rosenbergii with 542 citations (Fig. 1).
Lactobacillus sp. are found in the healthy intestines of prawns and
some species found in the gut possess antimicrobial activity in V. harveyi.
Dietary application of various Lactobacillus sp. (Ahmmed et al., 2020),
sporogenes (Seenivasan et al., 2016, 2014, 2012; Venkat et al., 2004) and
plantarum (Dash et al., 2015) for 60–90 days increased growth and feed
utilization parameters. Probiotics act as growth promoters when
administered as feed supplements for fishes and crustaceans, acceler
ating growth and positively modulating feed digestion. Among these,
Lactobacillus sp. and Lab. plantarum improved immunological parame
ters of prawn, thereby protecting against infections caused by V. harveyi
and A. hydrophila, respectively (Table 4). It is difficult to maintain the
desired concentration of Lactobacillus in the feed during storage because
of their non-spore forming nature, which limits their effectiveness to
counteract pathogens. Application of the yeast S. cerevisiae increased
digestive enzymes and amino acid production (Seenivasan et al., 2012)
and this species, similarly to L. sporogenes, L. acidophilus, is effective
enough to inhibit dominant gram-negative microflora in the intestine of
M. rosenbergii post-larvae (Venkat et al., 2004).
Table 3
Influence of probiotics on growth, feed utilization, immunological and haemato-biochemical parameters, gene expression and disease resistance in tiger shrimp
(Penaeus monodon). Symbol: (→) no change; (↑) increase; (↓) decrease.
Probiotics Mode of administration and dosage Duration Effects on Penaeus monodon References
Bacillus S11 Dietary supplementation at 2 × 102
CFU g–1
100 days GP WG↑; SR↑; WQP Temp, DO, pH, Nitrate & Phosphate→;
BC Vibrio↓, and Bacillus S11↑; IDR Vibrio sp. & Vibrio harveyi↑
(Rengpipat et al.,
1998)
Bacillus S11 Dietary supplementation at 102
CFU g–1
90 days GP WG↑; SR↑; IP THC, PcA, proPO & HBA↑; BC Vibrio↓, and
Bacillus S11↑; IDR Bacillus S11 & V. harveyi↑
(Rengpipat et al.,
2000)
Bacillus P11 Dietary supplementation at 3.9 × 108
-
3.6 × 109
CFU g–1
90 days GP WG↑; FUP FCR↓; SR↑; CM↓; IDR V. harveyi↑ (Utiswannakul
et al., 2011)
Bacillus sp. JL47 Fed with Artemia nauplii enriched with
probiotic
15 days IRGE proPO, TGase & HSP70↑ (Laranja et al.,
2017)
Bacillus S11 & Ozone (O3) Dietary supplementation at 1010
CFU g–1
30 days SR↑ (Meunpol et al.,
2003)
Bacillus subtilis, B. polymyxa, B.
megaterium, B. licheniformis &
B. thuringiensis
Dietary supplementation at 9.98
± 1.53 × 101
CFU mL–1
9.29 ± 2.01 × 101
CFU g–1
120 days GP WG, LG & SGR↑; FUP FER↓; SR↑; BC Bacillus (Hp & It)
↑& Bacillus (CW)→, and Vibrio (Hp, It, & CW) ↓; WQP Temp,
pH, Salinity, TDS, Nitrite & nitrate→
(Boonthai et al.,
2011)
B. coagulans, B. firmus, & B. coagulans
+ B. firmus
Dietary supplementation at 3.6 × 109
,
3.01 × 109
& 3.9 × 109
CFU g–1
14 days GP FBW, LG, WG & SGR↑; FUP FCR↓; SR↑; HBP Protein,
Lipid & Carbohydrates (Muscle & Hp)↑; IP THC, RB & proPO↑;
BC Vibrio↓
(Kolanchinathan
et al., 2017)
B. subtilis + B. licheniformis Dietary supplementation at 104
–108
CFU g–1
7 weeks DEA PrA, AmA, Cellulase & Lipase ↑ (Wang et al., 2020)
B. cereus Dietary supplementation at 1–5% 90 days GP FBW, WG & SGR↑; FUP FCR↓, and FCE↑; IP THC, proPO,
SOD, PPC, RB & SL↑; BC Haemolymph↓
(Chandran et al.,
2017)
B. cereus Dietary supplementation at 0.1–0.4% 100 g–1
90 days GP FBW & SGR↑; FUP FCR↓, and FCE↑; IP HBA, PPC, THC,
ProPO & SL↑; WQP Temp, pH & DO→, and Ammonia &
Alkalinity↑
(Chandran et al.,
2014)
Pseudomonas sp. PM 11 & V. fluvialis PM
17
Water supplementation at 103
CFU mL–1
45 days IP THC, proPO & HBA→ (Alavandi et al.,
2004)
Lab. acidophilus 04 Dietary supplementation at 105
CFU g–1
30 days GP FBW &WG↑; SR↑; BC Lactobacillus in CW↑, and Vibrio in
GIT↓
(Sivakumar et al.,
2012)
Lactobacillus sp. AMET1506 Dietary supplementation at 106
CFU g–1
30 days GP WG↑; SR↑; BC E. coli & THB↓, and Vibrio & Lactobacillus↑ (Karthik et al.,
2014)
Clostridium butyricum Dietary supplementation at 109
CFU g–1
56 days GP FBW, WG & SGR↑; FUP FCR↓; SR Nitrite Stress↑; DEA
AmA, Lipase & Trypsin↑; IP SOD, CAT & GPx↑; IRGE HSP70 &
FER↑
(Duan et al., 2019)
B. subtilis & Enterococcus sp. Dietary supplementation at 3 mL probiotic
suspension kg–1
84 days GP WG & LG↑, and SGR→; DEA Trypsin↑, and
Chymotrypsin↓; IDR V. harveyi↑;
(Nimrat et al., 2013)
Streptococcus phocae PI80, Enterococcus
faecium MC13, & Lactococcus garvieae
LC149 & B49
Dietary supplementation at 107
CFU mL–1
100 days GP FBW & SGR (PI80, MC13) ↑, and FBW & SGR (LC149 & B49)
↓; SR↑; IDR V. harveyi (PI80) and V. parahaemoliticus (MC13)↑
(Swain et al., 2009)
Streptomyces Dietary supplementation at 2.5–10 g kg–1
25 days GP WG & LG↑; SR↑; WQP Temp, DO, pH, Nitrate, Phosphate
& Silicate↑, and Ammonia & Salinity↓; BC THB↑, and Vibrio↓
(Das et al., 2006)
B. licheniformis TSK71, B.
amyloliquefaciens SK27, B. subtilis
SK07, Pseudomonas sp. ABSK55
Water supplementation at 109
CFU mL–1
120 days Immune response↑; IDR V. alginolyticus & V. harveyi↑ (Fernandes et al.,
2021)
B. coagulans & B. frmus Dietary supplementation at 3.01 × 109
,
3.91 × 109
, 3.65 × 109
, 3.73 × 109
,
3.9 × 109
& 3.81 × 109
CFU g− 1
30 days GP SGR & WG↑; FUP FCR↓; GutM ↑ (Kolanchinathan
et al., 2022)
AmA: Amylase activity; BC: Bacterial counts, CAT: Catalase; CM: Cumulative mortality; CW: Culture water; DEA: Digestive enzyme activities; DO: Dissolved oxygen;
FBW: Final body weight; FCE: Feed conversion efficiency; FCR: Feed conversion ratio; FER: Feed efficiency ratio; FUP: Feed utilization parameters; GIT: Gastroin
testinal tract; GP: Growth parameters; GPx: Glutathione peroxidase; GutM: Gut microbiota; HBA: Heamolymph bactericidal activity; HBP: Haemato-biochemical
parameters; Hp: Hepatopancreas; HSP: Heat shock protein; IDR: Infectious disease resistance; IP: Immunological parameters; IRGE: Immune related gene expres
sion; It: Intestine; LG: Length gain (%); PcA: Phagocytic activity; PPC: Plasma protein concentration; proPO: Prophenoloxidase; RB: Respiratory burst (NBT assay); SGR:
Specific growth rate (%); SL: Serum lysozyme; SOD: Superoxide dismutase; SR: Survival rate; TDS: Total dissolved solids; Temp: Temperature; TGase: Trans
glutaminase; THB: Total heterotrophic bacteria; THC: Total haemocyte count; WG: Weight gain (%); WQP: Water quality parameters.
T.A. Sumon et al.
9. Aquaculture Reports 25 (2022) 101220
9
Bacillus is effective in the biocontrol of Vibrio sp. infection, which is
consistent with its antagonistic relationship with other bacterial path
ogens. In cultured fish and shellfish, this group of probiotics acts as
growth promotors by elevating digestive enzymes activities, improving
feed utilization (Fig. 3). Leonel Ochoa-Solano and Olmos-Soto (2006)
reported the exoenzymes, lipase, amylase and protease production
stimulated by Bacillus after dietary administration of these probiotics.
Application with different Bacillus species like B. subtilis (Keysami et al.,
2012; Keysami and Mohammadpour, 2013), B. coagulans (Gupta et al.,
2016), B. coagulans (Kumar et al., 2013) and Bacillus NL110 (Rahiman
et al., 2010) improved growth and feed utilization of M. rosenbergii. In
the intestine, probiotics cell wall components bind with toll-like re
ceptors, inducing the activity of immune enzymes and cytokines (Hasan
et al., 2019), resulting in immunity upregulation in fish. Some in
vertebrates respond comparably to these LABs; feeding of M. rosenbergii
with B. pumilus (Zhao et al., 2019), cereus (Wee et al., 2018) and vireti 01
(Hindu et al., 2018) improved innate immune parameters resulting in
infection resistance against A. hydrophila and P. aeruginosa. Pyrrolo [1,
2-a] pyrazine-1,4-dione, hexahydro- of Bacillus bacteria acts as a po
tential antioxidant to counter the oxidative damage caused by O2 free
radicals (Kiran et al., 2018). Among these above-mentioned probiotics,
B. vireti 01, B. coagulans and B. pumilus improved digestive enzyme ac
tivity and B. coagulans modulated the intestinal microbial community.
However, mixture of B. subtilis and B. licheniformis (Frozza et al., 2021)
and B. subtilis (Keysami et al., 2012) showed no effect on growth and
water quality parameters of prawn, respectively. Most of these Bacillus
probiotics were isolated and identified from M. rosenbergii intestine and
supplemented for 60 days.
Commercial probiotics, Zymetin (B. mesentericus, C. butyricum, &
E. faecalis) supplementation for 240 and 60 days increased total pond
production of Macrobrachium sp. prawns (Ghosh et al., 2016) and im
munity along with intestinal and the ambient water microbial popula
tion (Azad et al., 2019), respectively. Similar concentrations (2 ×109
CFU g–1
) of C. butyricum (Sumon et al., 2018) and E. faecalis (Khushi
et al., 2020) resulted in identical positive modulation in terms of growth,
immunity, digestive enzymes and protection against V. harveyi after 60
days feeding of prawn.
4.4. Crab, crayfish and lobster
The application of probiotics in the culture of other crustaceans, such
as the decapods crab, crayfish, and lobsters, has recently attracted the
attention of researchers and the aquaculture sector as a prospective
strategy for preventing disease outbreaks and enhancements of pro
ductivity (Fig. 3). Nonetheless, there have only been a few investigations
on the effects of probiotics on these species, with only 18 studies found
Fig. 3. Effect of probiotics on cultured shellfish. Different types of probiotics like Aeromonas, Bacillus, Lactobacillus and Clostridium etc. are applied either through
feeding or directly into the waterbody and they propagate the digestion and growth of shellfishes. Besides, immune related genes and other immune parameters also
improved following the probiotic administration. Probiotics also assist in improving the water quality parameters by removing toxic substances from the water and
improve resistances against many bacterial and viral diseases.
T.A. Sumon et al.
10. Aquaculture Reports 25 (2022) 101220
10
in the Scopus database (Fig. 1). The outcomes of these experiments are
outlined in Table 5.
The effects of probiotics on cultured crab have been inadequately
investigated. In crab aquaculture, only a few probiotic agents are used:
Bacillus, Lactobacillus, Enterococcus and Pediococcus. Available data
revealed that these probiotics are capable of enhancing disease resis
tance, innate immunity, growth and survival of crab. Yang et al. (2019)
administered Enterococcus faecalis Y17 and Pediococcus pentosaceus G11
to mud crab (Scylla paramamosain) at 109
CFU g–1
for 6 weeks and
exposed the crab to V. parahaemolyticus. Both strains effectively modu
lated the crab’s immune responses, with considerably higher expression
of numerous genes in the hepatopancreas and elevated activity of im
mune indicators prophenoloxidase, serum lysozyme, and superoxide
dismutase in the hemolymph. Moreover, better growth performance and
higher survival rate in probiotic-fed crab were reported throughout the
challenge test, as compared to the controls. When employing B. subtilis
E20, however, there was no significant improvement in feed utilization,
growth, or survival rate of mud crab (Yeh et al., 2014). In another study,
Boonyapakdee and Bhujel (2020) demonstrated addition of
B. licheniformis kmp-9 to the diet of blue swimming crab (Portunus
pelagicus) improved the carapace length, weight gain, moulting per
centage and survival rate of the crab at the end of 45-day experiment. In
a 14-day study, a Lab. plantarum strain was incorporated into the rearing
water of P. pelagicus larvae at various concentrations, yielding not only
improved water quality but also significantly increased protease and
amylase enzyme activity of the crab (Talpur et al., 2013).
There is a scarcity of information on the efficiency of probiotics in
lobsters since there are realtively few studies on the topic, and also
because lobster farming is not particularly widespread. Despite this,
available data suggest that probiotic administration improved several
features of cultured lobsters, including growth, survival rate, gut
microbiota, and stress tolerance (Table 5). Juveniles of the spiny lobster
(Panulirus ornatus) were fed B. pumilus B3.10.2B and a multi-strain
probiotic containing B. pumilus B3.10.2B, B. cereus D9, and Lab. plan
tarum T13 for 60 days, and then challenged with a pathogen, V. owensii
(V. D. Nguyen et al., 2014). Juveniles under the probiotic treatments
exhibited enhanced growth and improved feed conversion rates, as well
as a higher survival rate after pathogen challenge than those in the
Table 4
Influence of probiotics on growth, feed utilization, immunological and haemato-biochemical parameters, and disease resistance in giant river prawn (Macrobrachium
rosenbergii). Symbol: (→) no change; (↑) increase; (↓) decrease.
Probiotics Mode of administration and dosage Duration Effects on Macrobrachium rosenbergii References
Zymetin (Bacillus mesentericus,
Clostridium butyricum, Enterococcus
faecalis)
Dietary supplementation at 5 g kg–1
60 days SR↑; IP THC, DHC, PcA & Clearance efficiency↑; GutM↑; Water
Microbiota↑; IDR Vibrio spp. & Aeromonas spp.↑
(Azad et al., 2019)
C. butyricum Dietary supplementation at 2 × 109
CFU
g–1
60 days GP FBW, WG & SGR↑; IP THC & DHC →; DEA PrA & AmA↑;
IDR V. harveyi↑
(Sumon et al., 2018)
Lactobacillus sp. Dietary supplementation at 2 × 109
CFU
g–1
8 weeks GP WG & SGR↑; IP DHC ↑, and THC→; DEA PrA & AmA↑; IDR
V. harveyi↑
(Ahmmed et al., 2020)
Enterococcus faecalis Dietary supplementation at 2 × 109
CFU
g–1
60 days GP WG & SGR↑; IP DHC ↑, and THC→; DEA PrA & AmA↑; IDR
V. harveyi↑
(Khushi et al., 2020)
Lactobacillus sporogenes, B. subtilis, &
Saccharomyces cerevisiae
Dietary supplementation at 1, 2, 3 & 4% 90 days GP WG & SGR↑; FUP FCR↓, and PER↑; SR↑; EUP FR, AR, CR,
NH3 ER & MR↑
(Seenivasan et al., 2012)
Lab. sporogenes, B. subtilis, &
S. cerevisiae
Dietary supplementation at 1, 2, 3 & 4% 60 days GP WG & SGR↑; SR↑; FUP FCR↓, and PER↑; DEA PrA, AmA &
Lipase↑
(Seenivasan et al., 2016)
Lab. sporogenes Dietary supplementation at 1, 2, 3 & 4% 90 days GP WG & SGR↑; SR↑; FUP FCR↓, and PER↑; EUP FR, AR, CR &
NH3↑
(Seenivasan et al., 2014)
Lab. acidophilus & Lab. sporogenes Dietary supplementation at 140 × 1011
&
24 × 107
CFU 100 g–1
60 days GP WG & SGR↑; SR↑; FUP FER & PER↑ (Venkat et al., 2004)
Lab. plantarum Dietary supplementation at 107
, 108
&
109
CFU g–1
90 days GP WG & SGR↑; FUP FCR↓, and PER↑; IP THC, PO, RB &
clearance efficiency↑; IDR A. hydrophila↑
(Dash et al., 2015)
B. pumilus Dietary supplementation at 107
, 108
&
109
CFU g–1
60 days GP WG, SGR & FBW↑; IP RB, CAT, PcA, ACP, NOS & PO↑ and
SOD→; DEA PrA & AmA↑, and Lipase→; SR↑
(Zhao et al., 2019)
B. subtilis Dietary supplementation at 108
CFU g–1
60 days GP WG & SGR↑; FUP FCR↓; SR↑; WQP Temp, DO, pH &
Ammonia→; GutM↓
(Keysami et al., 2012)
B. subtilis Dietary supplement at 108
CFU g–1
60 days GP WG & SGR↑; FUP FCR↓; SR↑; IDR A. hydrophila↑ (Keysami and
Mohammadpour, 2013)
B. coagulans Dietary supplement at 105
, 107
& 109
CFU g–1
60 days GP FBG & SGR↑; FUP PER↑; IP RB & SL↑; SR↑; DEA PrA, AmA
& Lipase↑; IDR V. harveyi↑
(Gupta et al., 2016)
B. licheniformis Dietary supplementation at 106
, 107
, 108
& 109
CFU g–1
60 days GP WG & SGR↑; FUP FCR↓; IP THC, SOD & PO↑; SR→; GutM
TBC & Bacillus spp.↑, and Pseudomonas spp. & Aeromonas spp.↓;
IDR V. alginolyticus↑
(Kumar et al., 2013)
B. cereus Dietary supplementation at 104
CFU g–1
28 days GP WG & SGR↑; SR→; IP SOD↑, and MDA→; IDR A. hydrophila
↑
(Wee et al., 2018)
B. subtilis + B. licheniformis Dietary supplementation at 1.08 × 105
,
2.17 × 105
& 1.08 × 105
CFU g–1
40 days GP WG, FBW & SGR→; FUP FCR→; SR↑; (Frozza et al., 2021)
B. vireti 01 Dietary supplementation at 108
CFU g–1
14 days IP SOD, CAT & GSH↑; SR↑; DEA PrA & Lipase↑; IDR
P. aeruginosa↑
(Hindu et al., 2018)
Bacillus NL110 & Vibrio NE17 Dietary & culture water supplementation
at (4.34 & 3.16) × 109
CFU g–1
respectively
60 days GP WG & SGR↑; FUP FCR↓; IP THC, RB & PO↑; SR↑; WQP
Nitrate & Ammonia↓
(Rahiman et al., 2010)
Zymetin (B. mesentericus, C.
butyricum, & E. faecalis)
Dietary supplementation at 1.10 × 106
CFU g–1
240 days GP WG & SGR↑; FUP PER↑, and FCR↓; TPP↑ (Ghosh et al., 2016)
ACP: Acid phosphatase; AmA: Amylase activity; AR: Absorption rate; CAT: Catalase; CR: Conversion rate; DEA: Digestive enzyme activities; DHC: Differential hae
mocyte count; DO: Dissolved oxygen; EUP: Energy utilization parameters; FBW: Final body weight; FC: Feed co-efficiency; FCR: Feed conversion ratio; FER: Feed
efficiency ratio; FR: Feeding rate; FUP: Feed utilization parameters; GP: Growth parameters; GPx: Glutathione peroxidase; GSH: Serum glutathione; GutM: Gut
microbiota; HSP70: Heat shock protein; IDR: Infectious disease resistance; IRGE: Immune related gene expression; MR: Metabolic Rate; NH3ER: Excretory rate; NOS:
Total nitric oxide synthase; PcA: Phagocytic activity; PER: Protein efficiency ratio; PO: Phenoloxidase activity; PrA: Protease activity; RB: Respiratory burst (NBT
assay); SGR: Specific growth rate (%); SL: Serum lysozyme; SOD: Superoxide dismutase; SR: Survival rate; TBC: Total bacterial count; Temp: Temperature; THC: Total
haemocyte count; TNF: Tumor necrosis factor; TPP: Total pond production; WG: Weight gain (%); WQP: Water quality parameters.
T.A. Sumon et al.
11. Aquaculture Reports 25 (2022) 101220
11
control group. Similarly, Daniels et al. (Daniels et al., 2013) found that
feeding European lobsters (Homarus gammarus) Bacillus spp. at
100 mg L-1
for 12 days improved weight gain, carapace length, and
survival, along with increased tolerance to salinity stress. Conversely,
the same probiotic was used as a water supplement for 18 days and had
no effect on the lobster’s growth performance or tolerance to increased
salinity (Middlemiss et al., 2015).
Studies on the efficacy of probiotics on crayfish are still in the early
stages, as no research on this topic had been carried out until a few years
ago. Recently, a few trials have been conducted to evaluate the impacts
of dietary probiotics like Bacillus and Lactobacillus on three crayfish
species: freshwater crayfish marron (Cherax cainii), red swamp crayfish
(Procambarus clarkii), and narrow clawed crayfish (Astacus leptodactylus)
(Foysal et al., 2020a, 2020b, 2021, 2019; Lai et al., 2020b; Valipour
et al., 2019; Xu et al., 2021). Foysal et al. (2021) investigated the effect
of Lab. plantarum on gut health and immunity of marron by feeding
probiotic at 109
CFU mL–1
for 56 days. Post-trial data revealed Lab.
plantarum significantly improved gut microbiota diversity and
morphology, and elevated immune responses, including increased total
hemocyte count, lysozyme activity and upregulated expression of
several immune-system associated genes in the gut tissues. In another
study, the same research group demonstrated similar improvement in
overall health of gut and immune responses of marron following the
combined administration of Lab. acidophilus and Lab. plantarum (Foysal
et al., 2020b). Neither of these studies demonstrated insignificant im
pacts of probiotic supplementation on growth parameters of marron. Xu
et al. (2021) isolated B. amyloliquefaciens A23 from the intestines of
healthy red swamp crayfish. The authors assessed the effects of the
probiotic on swamp crayfish by feeding them a diet for 28 days con
taining the isolated strain at 107
& 108
CFU g–1
. The findings indicated
that this probiotic successfully ameliorated the activities of intestinal
and innate immune enzymes of swamp crayfish and conferred protec
tion against white spot syndrome virus (WSSV).
4.5. Abalone and oyster
Studies of the efficacy of probiotics on molluscan shellfish are sparse
when compared to those on crustacean shellfish. Nevertheless, abalone
and oyster are the most investigated molluscan species for probiotics
applications, with 17 and 9 articles in Scopus, respectively. In Table 6,
findings of these researches are summarized.
A range of probiotics has reportedly been tested in the aquaculture of
various abalone species, including Bacillus, Lactobacillus, Exiguobacte
rium, Vibiro, Enterococcus, among others. The majority of these trials
employed dietary administration for probiotics treatment and docu
mented a multitude of benign responses, e.g., enhanced immunity,
greater immune gene expression, increased digestive enzyme activity,
and improved growth and survival rates (Fig. 3). For example, autoch
thonous Lab. pentosus was incorporated into the diet of abalone (Haliotis
discus hannai Ino) for eight weeks at 103
, 105
and 107
CFU g–1
(Gao et al.,
2018b). The immune responses of probiotic-fed abalone were signifi
cantly enhanced, exhibiting higher PcA, RB, CAT, SOD, ACP, and SL, as
Table 5
Influence of probiotics on growth, feed utilization, immunological and haemato-biochemical parameters, and disease resistance in crab, lobster and crayfish. Symbol:
(→) no change; (↑) increase; (↓) decrease.
Shellfish species Probiotics Mode of administration and
dosage
Duration Effects on host References
Mud crab (Scylla
paramamosain)
Enterococcus faecalis Y17 & Pediococcus
pentosaceus G11
Dietary supplementation at
109
CFU g–1
6 weeks GP FBW, WG & SGR↑; IP CAT, PO, SL, SOD &
THC↑; IRGE CAT, SL, proPO & SOD↑; IDR Vibrio
parahaemolyticus↑
(Yang et al., 2019)
S. paramamosain Bacillus subtilis DCU, B. pumilus BP &
B. cereus HL7
Dietary supplementation at
105
CFU g–1
30 days IP RB↑; IRGE CAT, proPO & SOD↑; IDR
V. parahaemolyticus↑
(Wu et al., 2014)
S. paramamosain B. subtilis E20 Dietary supplementation at
108
, 109
& 1010
CFU kg–1
28 days GP FBW→; FUP FCR→; SR→; IP PO & PcA↑,
IDR V. parahaemolyticus↑
(Yeh et al., 2014)
Blue swimming crab
(Portunus pelagicus)
Lab. plantarum PPG-2–10-Talpur Water supplementation at
106
, 5 × 106
& 107
CFU
mL–1
14 days SR↑; DEA PrA & AmA↑; WQP Ammonium &
pH→; Total bacteria and Vibrio counts in
water↓
(Talpur et al., 2013)
Blue swimming crab
(P. pelagicus)
B. licheniformis kmp-9 Dietary supplementation at
1.5, 3 & 6 mL kg–1
45 days GP WG, CL & Moulting ↑; SR↑; FUP FCR ↓;
Vibrio count↓
(Boonyapakdee and
Bhujel, 2020)
Ornate spiny lobster
(Panulirus ornatus)
Bacillus pumilus B3.10.2B & B. pumilus
B3.10.2B + Bacillus cereus
D9 + Lactobacillus plantarum T13
Dietary supplementation at
109
CFU mL–1
60 days GP FBW & SGR↑; FUP FCR↓; IDR Vibrio
owensii↑
(V. D. Nguyen et al.,
2014)
European lobster
(Homarus gammarus)
Bacillus spp. Dietary supplementation at
100 mg L–1
12 days GP FBW, WG & CL↑; SR↑; Vibrio levels ↑;
GutM Bacillus↑; ESC Low salinity↑
(Daniels et al.,
2013)
H. gammarus Bacillus spp. Water supplementation at
3.5 × 107
CFU L–1
18 days GP WG & CL→; ESC Low salinity→; Vibrio
like spp. in water↑
(Middlemiss et al.,
2015)
Marron (Cherax cainii) Lab. plantarum Dietary supplementation at
109
CFU mL–1
56 days GP WG & SGR→; FUP FCR→; IP THC & SL↑;
IRGE proPO, SL, ALF, Toll & CTL↑; GutM↑;
IFH↑; IDR V mimicus↑
(Foysal et al., 2021)
C. cainii Lab. acidophilus + Lab. plantarum Dietary supplementation at
109
CFU mL–1
60 days GP WG→ and SGR↑; FUP FCR↓; IP THC & SL↑;
IRGE proPO, cytMnSOD, IL8, IL10, IL17F & IL1β
↑; GutM↑; Microvilli count↑
(Foysal et al., 2020)
Red swamp crayfish
(Procambarus clarkii)
B. amyloliquefaciens Dietary supplementation at
5 g kg–1
72 h IDR WSSV↑; IRGE TLR, CLT & NF-κB↑; IR
THC↑
(Lai et al., 2020)
Red swamp crayfish
(Procambarus clarkii)
B. amyloliquefaciens A23 Dietary supplementation at
107
& 108
CFU g–1
28 days DEA AmA, Trypsin & Lipase↑; IR SL, SOD &
ACP↑; GutM↑; IDR WSSV↑
(Xu et al., 2021)
Narrow clawed crayfish
(Astacus leptodactylus)
Lab. plantarum Dietary supplementation at
107
, 108
& 109
CFU g–1
97 days GP WG & SGR→; DEA PrA, AmA, ALP &
Lipase↑; IR THC, TPP, PO, SL, SOD & CAT↑;
GutM↑; SR→
(Valipour et al.,
2019)
ALF: Anti-lipopolysaccharide factor; AmA: Amylase activity; CAT: Catalase; CL: Carapace length; CTL: C-type lectin; cytMnSOD: cytosolic manganese superoxide
dismutase; DEA: Digestive enzyme activities; ESC: Environmental stress challenge; FBW: Final body weight; FCR: Feed conversion ratio; FUP: Feed utilization pa
rameters; GP: Growth parameters; GPx: Glutathione peroxidase; GutM: Gut microbiota; IDR: Infectious disease resistance; IFH: Intestinal fold height; IL: Interleukin; IP:
Immunological parameters; IRGE: Immune related gene expression; mVH: micro-Villous height; NF-κB: Nuclear factor-κB; PcA: Phagocytic activity; PO: Phenoloxidase;
PrA: Protease activity; proPO: Prophenoloxidase; RB: Respiratory burst (NBT assay); SGR: Specific growth rate (%); SL: Serum lysozyme; SOD: Superoxide dismutase;
SR: Survival rate; THC: Total hematocyte count; TLR: Toll like receptor; TPP: Total plasma protein; W/CL ratio: Weight and carapace length ratio; WG: Weight gain
(%); WQP: Water quality parameters.
T.A. Sumon et al.
12. Aquaculture Reports 25 (2022) 101220
12
well as elevated expression of HSP70, TPx, CAT, and MnSOD. In addi
tion, probiotics increased feed efficiency, overall survival rate and
reduced mortality during challenge test with V. parahaemolyticus. In
another experiment, Xiaolong et al. (2020) obtained analogous out
comes in the same abalone species, as well as substantially increased
activity of intestinal enzymes, at the end of a 70-day feeding trial with
B. lincheniformis ge6–1. Administration of multi-strain probiotics in
farmed abalone have also been reported. Host-derived bacterial strains,
Exiguobacterium JHEb1, Vibrio JH1 and Enterococcus JHLDc, were added
in combination to the diet of New Zealand abalone H. iris at varied doses.
Post-trial data revealed that multi-strain probiotics brought various
beneficial effects in the abalone such as significantly improved shell
length, wet weight, and survival rate (Hadi et al., 2014), immune
response (Grandiosa et al., 2018) and resistance against V. splendidus
(Grandiosa et al., 2020).
The effects of probiotics on oysters have been studied minimally so
far; nearly all of the research that has been performed has focused on
growth performance, survival rate, or pathogen resistance. Aguilar-
Macías et al. (2010) investigated the survival and growth of juvenile
pearl oyster, (Pinctada mazatlanica) fed microalgae supplemented with
several probiotics such as Lactobacillus sp. NS6.1, Burkholderia cepacian
Y021 + Pseudomonas aeruginosa YC58, and Yarrowia lipolytica 020 for 21
days at 106
CFU mL–1
. When compared to non-probiotic fed oysters,
probiotic treated oysters had considerably improved shell length, weight
gain, and survival rate. After being fed a diet enriched with the same
probiotics for 30 days, Cortez oysters (Crassostrea corteziensis) also
demonstrated similar improvements in growth and survival (Cam
pa-Córdova et al., 2009). Sohn et al. (2016) administered two probiotic
strains, Phaeobacter inhibens S4 and Bacillus pumilus RI06–95, in the
rearing water of Eastern oyster (C. virginica) larvae at 104
CFU mL–1
for
two weeks. Results revealed that probiotics conferred protection against
V. coralliilyticus and Roseovarius crassostreae. Similar probiotic treat
ments, on the other hand, had no effect on the growth and survival of
larval oysters.
Some probiotic candidates appear to have potential protective value
in oyster larviculture, promoting resistance to challenges with Vibrio spp.
and other pathogens (Karim et al., 2013; Lim et al., 2011).
5. Conclusions and future prospects
A sense of urgency has arisen for the transition from the use and
overuse of antibiotics to control pathogens in aquaculture. The effec
tiveness of antibiotics is counteracted by selection favouring resistant
strains, leading to the emergence of dangerously capable pathogens. The
generation and proliferation of such pathogens is particularly threat
ening in the culture of human food organisms. The dangers of routine
antibiotic applications are well-recognized now, and alternatives are
critically needed. Probiotics are being marketed to aquaculture pro
fessionals, but it is generally true that their effectiveness in any given
situation is uncertain. Probiotic organisms decrease the likelihood of the
impairment or mortality of culture subjects by pathogens through a
poorly understood complex of mechanisms, and more specific
Table 6
Influence of probiotics on growth, feed utilization, immunological and haemato-biochemical parameters, and disease resistance in abalone and oyster. Symbol →, no
change; ↑, increase; ↓, decrease versus controls.
Shellfish species Probiotics Mode of administration
and dosage
Duration Effects on host References
New Zealand
abalone
(Haliotis iris)
Exiguobacterium JHEb1, Vibrio JH1 &
Enterococcus JHLDc
Dietary supplementation
at 3 × 109
CFU g–1
60 days GP WG & Shell length↑; SR↑ (Hadi et al., 2014)
H. iris Exiguobacterium JHEb1, Vibrio JH1 &
Enterococcus JHLDc
Dietary supplementation
at 2 × 109
CFU g–1
4
months
GP WG & Shell length↑; IR THC, ROS↑ (Grandiosa et al.,
2018)
H. iris Exiguobacterium JHEb1, Vibrio JH1 &
Enterococcus JHLDc
Dietary supplementation
at 3 × 109
CFU g–1
4
months
IDR Vibrio splendidus↑ (Grandiosa et al.,
2020)
Abalone (Haliotis
asinine)
Bacillus amyloliquefaciens MA228,
Enterobacter ludwigii MA208 and
Pediococcus acidilactici MA160
Dietary supplementation
at ~ 107
CFU mL− 1
62 days GP FBW, SGR & Shell length ↑; SR→; Bacteria
count in water↑
(Amin et al., 2020)
Abalone (Haliotis
diversicolor)
B. stratosphericus A3440, Phaeobacter
daeponensis AP1220 and their mixture
Dietary supplementation
at ~ 108
CFU g–1
180 days GP WG & Shell length↑; DEA Lipase & Trypsin↑; IP
ALP, ACP, SOD, CAT & GPx↑; IDR V. harveyi↑
(Zhao et al., 2018)
Abalone (H. discus
hannai)
B. lincheniformis ge6–1 Dietary supplementation
at 105
CFU g–1
70 days GP SGR↑; FUP FCE & FI↑; SR↑; DEA PrA, AmA,
Lipase & Cellulase↑; IR THC, PcA, RB, SL, ACP, SOD &
CAT↑; IRGE CAT, TPx, HSP70, MnSOD↑; IDR V.
parahaemolyticus↑
(Xiaolong et al.,
2020)
Abalone (H. discus
hannai Ino)
B. lincheniformis Dietary supplementation
at 103
, 105
& 107
CFU
mL–1
8 weeks GP SGR↑; FUP FCE & FI↑; SR↑; IP THC, PcA, RB, SL,
ACP, SOD, CAT & MPO↑; IRGE CAT, TPx, HSP70,
MnSOD↑; IDR V. parahaemolyticus↑
(Gao et al., 2018a)
Abalone (H. discus
hannai Ino)
Lactobacillus pentosus Dietary supplementation
at 103
, 105
& 107
CFU g–1
8 weeks GP SGR↑; FUP FCE & FI↑; SR↑; IP THC, PcA, RB, SL,
ACP, SOD & CAT↑; IRGE CAT, TPx, HSP70, MnSOD↑;
IDR V. parahaemolyticus↑
(Gao et al., 2018b)
Abalone (H. discus
hannai Ino)
Shewanella colwelliana WA64 & S. olleyana
WA65
Dietary supplementation
at 109
CFU g–1
28 days IP THC, SL & RB↑, and SOD, ACP & PcA→; HBP TP↑;
IDR V. harveyi↑
(Jiang et al., 2013)
Cortes oyster
(Crassostrea
corteziensis)
Lactobacillus sp. NS61, Pseudomonas
aeruginosa YC58 + Burkholderia cepacia
Y021, Yarrowia lipolytica 020
Dietary supplementation
at 5 × 104
CFU mL–1
30 days GP↑; SR↑; IP SOD↑; HBP TP→ (Campa-Córdova
et al., 2009)
Eastern oyster
(C. virginica)
Phaeobacter inhibens S4 & B. pumilus
RI06–95
Water supplementation at
104
CFU mL–1
2 weeks GP→; SR →; IDR V. coralliilyticus & Roseovarius
crassostreae ↑
(Sohn et al., 2016)
C. virginica Phaeobacter sp. S4 & B. pumilus RI06–95 Water supplementation at
102
–106
CFU mL–1
24 h SR →; larvae IDR V. tubiashii & R. crassostreae ↑ (Karim et al., 2013)
Pearl oyster
(Pinctada
mazatlanica)
Lactobacillus sp. NS6.1, Burkholderia
cepacian Y021 + Pseudomonas aeruginosa
YC58, Yarrowia lipolytica 020
Dietary supplementation
at 106
CFU mL–1
21 days GP WG & Shell length↑; SR↑ (Aguilar-Macías
et al., 2010)
ACP: Acid phosphatase; AmA: Amylase activity; ALP: Alkaline phosphatase; CAT: Catalase; DEA: Digestive enzyme activities; FBW: Final body weight; FCE: Feed
conversion efficiency; FCR: Feed conversion ratio; FI: Food intake; FUP: Feed utilization parameters; GP: Growth parameters; GPx: Glutathione peroxidase; HBP:
Haemato-biochemical parameters; IDR: Infectious disease resistance; IP: Immunological parameters; IRGE: Immune related gene expression; MnSOD: Manganese
superoxide dismutase; MPO: Myeloperoxidase; PcA: Phagocytic activity; PrA: Protease activity; RB: Respiratory burst (NBT assay); SGR: Specific growth rate (%); SL:
Serum lysozyme; SOD: Superoxide dismutase; SR: Survival rate; THC: Total Haemocytes count; TP: Total protein; WG: Weight gain (%).
T.A. Sumon et al.
13. Aquaculture Reports 25 (2022) 101220
13
understanding of these mechanisms is highly desired. Moreover, pro
biotics contribute to the development of an unfavourable environment
for the proliferation of pathogens, thereby disabling pathogens to some
degree and preventing or minimizing outbreaks of infectious organisms.
Following numerous studies on probiotics use in aquaculture, most of
them explained the effects but they do not have detailed explanations of
the complete picture of the microbial community; for example we need
to know how the probiotics affect the microbiota or what is the meaning
of improving microbial community. Besides this, the relationship of
probiotic with growth performance or health status or disease resistance
of the shellfish is not yet fully explained beyond observations of certain
beneficial effects on them. In addition, we need a more complete
comprehension of probiotics with an understanding of the nuances of
any harmful potential they may have. For these reasons, addressing
these aspects could contribute to more effective use of probiotics in
shellfish aquaculture.
Funding
This study was supported by Brain Pool Scholarship (Grant no.:
2021H1D3A2A01099381) funded by National Research Foundation
(NFR), Republic of Korea, and NRF grant funded by the Korean gov
ernment Ministry of Science and ICT (Grant no.:
2020R1A2C10051761361782064340103).
Ethical statement
As no experiment was conducted, this manuscript does not need an
ethical approval.
CRediT authorship contribution statement
Tofael Ahmed Sumon: Conceptualization, Data curation, Formal
analysis, Software, Writing – original draft, Visualization. Md. Ashraf
Hussain: Conceptualization, Data curation, Formal analysis, Software,
Writing – original draft, Visualization. Md. Afsar Ahmed Sumon:
Conceptualization, Data curation, Writing – original draft. Won Je
Jang: Data curation, Writing – original draft. Francisco Guardiola
Abellan: Writing – review & editing, S.M. Sharifuzzaman: Writing –
review & editing. Christopher L. Brown: Writing – review & editing of
scholarly English. Eun-Woo Lee: Writing – review & editing. Chan-Hee
kim: Conceptualization, Data curation, Supervision, Software, Writing –
original draft, Funding acquisition. Md. Tawheed Hasan: Conceptual
ization, Data curation, Supervision, Software, Writing – original draft,
Funding acquisition.
Declaration of Competing Interest
The authors declare that they have no known competing financial
interests or personal relationships that could have appeared to influence
the work reported in this paper.
Data Availability
Data availability statementData sharing not applicable to this article
as no datasets were generated or analyzed during the current study.
References
Adel, M., Yeganeh, S., Dawood, M.A.O., Safari, R., Radhakrishnan, S., 2017. Effects of
Pediococcus pentosaceus supplementation on growth performance, intestinal
microflora and disease resistance of white shrimp, Litopenaeus vannamei. Aquac.
Nutr. 23, 1401–1409. https://doi.org/10.1111/anu.12515.
Adilah, R.N., Chiu, S.T., Hu, S.Y., Ballantyne, R., Happy, N., Cheng, A.C., Liu, C.H., 2022.
Improvement in the probiotic efficacy of Bacillus subtilis E20-stimulates growth and
health status of white shrimp, Litopenaeus vannamei via encapsulation in alginate and
coated with chitosan. Fish & Shellfish Immunology. Evaluation of natural and
commercial probiotics for improving growth and survival of the pearl oyster,
Pinctada mazatlanica, during late hatchery and early field culturing. J. World Aquac.
Soc. 41, 447–454.
Ahmmed, F., Ahmmed, M.K., Khushi, S.S., Sumon, M.S., Karamcheti, S.S., Sarower, M.G.,
2020. Host gut-derived probiotic Lactobacillus sp. improves resistance of giant
freshwater prawn Macrobrachium rosenbergii against Vibrio harveyi. Aquac. Int 28,
1709–1724. https://doi.org/10.1007/s10499-020-00551-y.
Ajitha, S., Sridhar, M., Sridhar, N., Bright Singh, I.S., Varghese, V., 2004. Probiotic effects
of lactic acid bacteria against Vibrio alginolyticus in Penaeus (Fenneropenaeus indicus
H. Milne Edwards). Asian Fish. Sci. 17, 71–80.
Akter, M.N., Hashim, R., Sutriana, A., Siti Azizah, M.N., Asaduzzaman, M., 2019. Effect
of Lactobacillus acidophilus supplementation on growth performances, digestive
enzyme activities and gut histomorphology of striped catfish (Pangasianodon
hypophthalmus Sauvage, 1878) juveniles. Aquac. Res. 50, 786–797. https://doi.org/
10.1111/are.13938.
Alavandi, S.V., Vijayan, K.K., Santiago, T.C., Poornima, M., Jithendran, K.P., Ali, S.A.,
Rajan, J.J.S., 2004. Evaluation of Pseudomonas sp. PM 11 and Vibrio fluvialis PM 17
on immune indices of tiger shrimp, Penaeus monodon. Fish. Shellfish Immunol. 17,
115–120. https://doi.org/10.1016/j.fsi.2003.11.007.
Amin, M., Bolch, C.J.S., Adams, M.B., Burke, C.M., 2020. Growth enhancement of
tropical abalone, Haliotis asinina L, through probiotic supplementation. Aquac. Int.
28, 463–475. https://doi.org/10.1007/s10499-019-00473-4.
Amoah, K., Huang, Q., Dong, X., Tan, B., Zhang, S., Chi, S., Yang, Q., Liu, H., Yang, Y.,
2020. Paenibacillus polymyxa improves the growth, immune and antioxidant activity,
intestinal health, and disease resistance in Litopenaeus vannamei challenged with
Vibrio parahaemolyticus. Aquaculture 518, 734563. https://doi.org/10.1016/j.
aquaculture.2019.734563.
Ayiku, S., Shen, J., Tan, B., Dong, X., Liu, H., 2020. Effects of dietary yeast culture on
shrimp growth, immune response, intestinal health and disease resistance against
Vibrio harveyi. Fish. Shellfish Immunol. 102, 286–295. https://doi.org/10.1016/j.
fsi.2020.04.036.
Azad, I.S., Panigrahi, A., Gopal, C., Paulpandi, S., Mahima, C., Ravichandran, P., 2005.
Routes of immunostimulation vis-a-vis survival and growth of Penaeus monodon
postlarvae. Aquaculture 248, 227–234.
Azad, M.A.K., Islam, S.S., Sithi, I.N., Ghosh, A.K., Banu, G.R., Bir, J., Huq, K.A., 2019.
Effect of probiotics on immune competence of giant freshwater prawn
Macrobrachium rosenbergii. Aquac. Res. 50, 644–657. https://doi.org/10.1111/
are.13942.
Beck, B.R., Song, J.H., Park, B.S., Kim, D., Kwak, J.H., Do, H.K., Kim, A.R., Kim, W.J.,
Song, S.K., 2016. Distinct immune tones are established by Lactococcus lactis BFE920
and Lactobacillus plantarum FGL0001 in the gut of olive flounder (Paralichthys
olivaceus). Fish. Shellfish Immunol. 55, 434–443. https://doi.org/10.1016/j.
fsi.2016.06.022.
Boonthai, T., Vuthiphandchai, V., Nimrat, S., 2011. Probiotic bacteria effects on growth
and bacterial composition of black tiger shrimp (Penaeus monodon). Aquac. Nutr. 17,
634–644. https://doi.org/10.1111/j.1365-2095.2011.00865.x.
Boonyapakdee, A., Bhujel, R., 2020. Determining the Dose of Dietary Probiotic (Bacillus
licheniformis) for the Nursing of Blue Swimming Crablets (Portunus pelagicus, L.,
1758). Turkish. J. Fish. Aquat. Sci. 20, 889–899. https://doi.org/10.4194/1303-
2712-v20_12_05.
Botić, T., Danø, T., Weingartl, H., Cencič, A., 2007. A novel eukaryotic cell culture model
to study antiviral activity of potential probiotic bacteria. Int. J. Food Microbiol. 115,
227–234.
Brunt, J., Hansen, R., Jamieson, D.J., Austin, B., 2008. Proteomic analysis of rainbow
trout (Oncorhynchus mykiss, Walbaum) serum after administration of probiotics in
diets. Vet. Immunol. Immunopathol. 121 (3–4), 199–205.
Butt, U.D., Lin, N., Akhter, N., Siddiqui, T., Li, S., Wu, B., 2021. Overview of the latest
developments in the role of probiotics, prebiotics and synbiotics in shrimp
aquaculture. Fish. Shellfish Immunol. 114, 263–281. https://doi.org/10.1016/j.
fsi.2021.05.003.
Cai, Y., Yuan, W., Wang, S., Guo, W., Li, A., Wu, Y., Chen, X., Ren, Z., Zhou, Y., 2019. In
vitro screening of putative probiotics and their dual beneficial effects: To white
shrimp (Litopenaeus vannamei) postlarvae and to the rearing water. Aquaculture 498,
61–71. https://doi.org/10.1016/j.aquaculture.2018.08.024.
Campa-Córdova, A.I., González-Ocampo, H., Luna-González, A., Mazón-Suástegui, J.M.,
Ascencio, F., 2009. Growth, survival, and superoxide dismutase activity in juvenile
Crassostrea corteziensis (Hertlein, 1951) treated with probiotics. Hidrobiológica 19,
151–157.
Cha, J.H., Rahimnejad, S., Yang, S.Y., Kim, K.W., Lee, K.J., 2013. Evaluations of Bacillus
spp. as dietary additives on growth performance, innate immunity and disease
resistance of olive flounder (Paralichthys olivaceus) against Streptococcus iniae and as
water additives. Aquaculture 402–403, 50–57. https://doi.org/10.1016/j.
aquaculture.2013.03.030.
Chabrillon, M., Ouwehand, A.C., Diaz-Rosales, P., Arijo, S., Martinez-Manzanares, E.,
Balebona, M.C., 2006. Adhesion of lactic acid bacteria to mucus of farmed gilthead
seabream, and interactions with fish pathogenic microorganisms. Bull. Eur. Assoc.
Fish. Pathol. 26, 202–210.
Chai, P.-C., Song, X.-L., Chen, G.-F., Xu, H., Huang, J., 2016. Dietary supplementation of
probiotic Bacillus PC465 isolated from the gut of Fenneropenaeus chinensis improves
the health status and resistance of Litopenaeus vannamei against white spot syndrome
virus. Fish. Shellfish Immunol. 54, 602–611. https://doi.org/10.1016/j.
fsi.2016.05.011.
Chandran, M.N., Iyapparaj, P., Moovendhan, S., Ramasubburayan, R., Prakash, S.,
Immanuel, G., Palavesam, A., 2014. Influence of probiotic bacterium Bacillus cereus
isolated from the gut of wild shrimp Penaeus monodon in turn as a potent growth
promoter and immune enhancer in P. monodon. Fish. Shellfish Immunol. 36, 38–45.
https://doi.org/10.1016/j.fsi.2013.10.004.
T.A. Sumon et al.